SCHEMBL18307151

SCHEMBL18307151

O=C1COc2cc(I)cnc2N1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.38
CYP11B1 P15538 2/20 0.37
CYP11B2 P19099 2/20 0.37
PARP1 P09874 1/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPT P10636 3/20 0.35
CRBN Q96SW2 4/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PKM P14618 1/20 0.34
GAA P10253 1/20 0.33
CHEK1 O14757 1/20 0.33
AURKA O14965 1/20 0.33
DAPK3 O43293 1/20 0.33
PRKD3 O94806 1/20 0.33
MAP4K4 O95819 1/20 0.33
ABL1 P00519 1/20 0.33
NTRK1 P04629 1/20 0.33
CSF1R P07333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3082129 0.80 ALDH1A1 (0.38) MMP12CYP11B1CYP11B2PARP1ALDH1A1
SCHEMBL7958200 0.80 MMP12 (0.38) MMP12CYP11B1CYP11B2PARP1ALDH1A1
SCHEMBL859012 0.80 MMP12 (0.38) MMP12CYP11B1CYP11B2PARP1ALDH1A1
SCHEMBL15979057 0.80 NR3C2 (0.39) MMP12CYP11B1CYP11B2NR3C2
SCHEMBL10283759 0.80 MMP12 (0.49) MMP12CYP11B1CYP11B2PARP1ALDH1A1
SCHEMBL17095009 0.78 PARP1 (0.37) MMP12CYP11B1CYP11B2PARP1ALDH1A1
SCHEMBL7326455 0.76 PARP1 (0.39) MMP12CYP11B1CYP11B2PARP1ALDH1A1
SCHEMBL13658043 0.76 TRPV1 (0.40) MMP12CYP11B1CYP11B2PARP1ALDH1A1
SCHEMBL21382790 0.76 GRM5 (0.36) MMP12CYP11B1CYP11B2PARP1ALDH1A1
SCHEMBL13748940 0.76 MMP12 (0.39) MMP12CYP11B1CYP11B2PARP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265607-B1 PYRIMIDINE-2-AMINE COMPOUNDS AND THEIR USE AS INHIBITORS OF JAK KINASES RIGEL PHARMACEUTICALS INC (US) 2016-12-14 EP disclosed